PALI
Palisade Bio, Inc.
$1.96
-0.01 (-0.51%)
At close · Jul 10
Market Cap
$340.22M
Shares
173,579,670
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.96
Open$1.99
Day$1.87–1.99
52W$0.53–2.86
Avg vol 30d4.0M
Short int32.1M · 18.5% float · 5.4d
Short vol62%
DataJan 2020–Jul 2026
Filing10-Q · May 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Bearish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+5%
above
Price vs 50-day avg
+2%
above
RSI (14)
50
neutral
MACD trend
Positive
52-week position
61%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+17%
trailing
6-month return
+12%
trailing
YTD return
−17%
this year
Relative strength
+3%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $2 — 50d above 200d
Institutional flow
Distributing
1 of 96 funds reported for Jun 30 · net -1.5K sh shares
Insider flow
Distributing
Net -$159.7K over 90 days · 67% sells
Short interest
Rising
18.51% of float · ▲ +1.9% MoM · 5.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
96 holders — near 2-yr high, broad support
Squeeze score
67
elevated · 0–100
Fundamentals
Revenue growth
+1500%
Y/Y
EPS growth
+97%
Y/Y
Free cash flow
$-10.8M
Valuation
P/E 16.3
in line
Balance sheet
$133.3M
net cash
Quant / Vol
risk profile
Volatility
127%
annualized · 1-yr
Max drawdown
−56%
past year
ATR
8.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+5%
Bullish
Price vs 50-day avg
+2%
Bullish
RSI (14)
50
Neutral
MACD trend
Positive
Bullish
52-week position
61%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $2 › 200d $2 — 50d above 200d
Institutional flow
Distributing
1 of 96 funds reported for Jun 30 · net -1.5K sh shares
Insider flow
Distributing
Net -$159.7K over 90 days · 67% sells
Short interest
Rising
18.51% of float · ▲ +1.9% MoM · 5.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
96 holders — near 2-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $2 · 61%
52-wk high $3
vs 200-day avg +5%
vs 50-day avg +2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PALI
this stock
Palisade Bio, Inc.
|
$340.22M | -16.6% | +1500.4% | 16.3 | 18.5% |
|
ONC
BeOne Medicines Ltd.
|
$431.70B | -1.7% | +22179.2% | 878.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +7.1% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.63B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +4.4% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PALI | -6.7% | +16.7% | +12.0% | -6.2% | -16.6% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | -8.0% | +12.6% | +2.9% | -7.3% | -27.3% |